Jefferies & Co

Jefferies & Co. has published a research report on WMS Industries (NYSE: WMS) in anticipation of company sales that are expected to ramp up throughout FY2011. In the report, Jefferies writes "We are revising our FY11 and FY12 unit sales and quarterly and full-year estimates to reflect a more...

Jefferies & Co. published a research report on Cubist Pharmaceuticals (NASDAQ: CBST) in anticipation of the company's 3Q results. In the report, Jefferies writes "We're positive on CBST given (1) Cubicin sales growth prospects (12% CAGR for '09-'14); (2) likely positive outcome from Cubicin...

Analysts at Jefferies & Co upgrade Magnum Hunter Resources Corporation (NYSE: MHR) from "hold" to "buy." The target price for MHR is set to $4.8. MHR's shares gained 3.38% to close at $4.28 on Friday. More Analyst Ratings here

Jefferies & Co. has published a research report for General Maritime (NYSE: GMR) following the company's amendment of its $372M credit facility to raise the $52.4 in equity needed to fund its most recent acquisition. In the report, Jefferies writes "Yesterday, General Maritime amended its $372...

Jefferies & Co. finds YUM! Brands (NYSE: YUM) attractive due to its opportunities for global growth, which are led by China and other developing nations. In a research report, Jefferies writes "believe the stock may tread water near term as 2H 2010 challenges appear from a margin and foreign...

Jefferies & Company is out with a research report this morning, where it reiterates its Hold rating on Beckman Coulter (NYSE: BEC); it has as a $47.00 price target on the stock, down from $50.00. The Jefferies analysts cited proprietary checks with several BEC lab customers to assess the state...

Jefferies & Co. has published a research report for Ceragon Networks (NASDAQ: CRNT) and has downgraded the company from Buy to Hold. In the report, Jefferies writes "Our enthusiasm is tempered by the timing and visibility of orders and the reality that selling to telcos is an elongated sale...

Jefferies & Co. has published a research report for Ventas Inc. (NYSE: VTR) reporting that solid growth can be expected while being fueled by acquisitions. In the report, Jefferies writes "Transaction highlights: 1) VTR will acquire SRZ's interests in 58 senior living communities for total...

Jefferies & Co. has published a research report for Weatherford International (NYSE: WFT) just as the story for the company starts getting interesting... In the report, Jefferies writes "We continue to await the FCPA fine against WFT, but the liquidity boost removes our uncertainty on how a...

Jefferies & Co. has published a research report for Inspire Pharmaceuticals Inc. (NASDAQ: ISPH) initiating coverage at Buy. In the report Jefferies writes "We believe Inspire's lead program, denufosol, will have statistically significant TIGER-2 data in 1Q:11, attain FDA approval in 2H:11, and...

Jefferies & Co. has published a research report for Boston Scientific Corporation (NYSE: BSX) with new coverage initiated. In the report, Jefferies writes "We are initiating coverage on Boston Scientific (BSX) with a Hold rating. Since its acquisition of Guidant in 2006, Boston has weathered a...

Couer d'Alene Mines (NYSE: CDE) is reaffirmed as a Buy from Jefferies, which writes “[We] are pleased to see Coeur report favorable results on exploration drilling at Palmarejo, Joaquin and Rochester. Joaquin looks attractive, especially considering it is located between Andean Resources' Cerro...

Pan American Silver (NASDAQ: PAAS) reported on its operations at the Denver Gold Forum that "Huaron, which had lagged in 1H10 due to poor ground conditions, is back on track in the third quarter due to improvement in throughput rates, silver grades and recoveries. We expect production at Huaron to...

SL Green Realty Corp. (NYSE: SLG) likely to post below-average FFO per share growth through 2013, according to Jefferies & Co. Jefferies has initiated coverage with a Hold rating and $62 price target, stating that: "[We] estimate that SL Green has total growth potential through 2013 related to...

BioMed Realty Trust, Inc. (NYSE: BMR) is having coverage initiated with a Hold rating and $19 price target by Jefferies & Co. The reason for the Hold is as follows: "We are positive on BMR's exposure to the secular growth of the life science industry and are relatively optimistic about its...